News

Crucially, type 1 diabetes is not related to diet and lifestyle choices. As the Diabetes UK website outlines, the exact ...
Mother of two becomes the first UK patient to receive ‘groundbreaking’ new diabetes drug - New drug offers future hope that ...
People with diabetes told to eat one popular fruit at certain time to lower blood sugar Diabetes is a chronic illness that causes high blood sugar, but eating one kind of banana could help manage ...
Type 2 diabetes study makes flagship dataset available to researchers worldwide; Diabetes UK, which is set to inherit £180,000, faced a legal dispute as the unique will was separated onto two boxes ...
Diabetes tests used in the UK may be putting tens of thousands of South Asian people at risk of getting false results, new research suggests. The research identified a genetic variant among people ...
Diabetes UK estimated a further 6.3 million people are living with non-diabetic hyperglycaemia, some of whom do not know they have the condition. More commonly known as pre-diabetes, ...
Millions of people with type 2 diabetes could receive better treatment thanks to a new, simple low-cost tool, according to groundbreaking research announced today at the Diabetes UK Professional ...
A new Government report reveals 1 million UK adults are likely to have undiagnosed diabetes and at least 5.1 million are prediabetic. Many of them will be young, of average weight and entirely ...
Diabetes in the UK at its highest level ever, with charity saying more than 5 million Britons live with condition. People who are overweight or obese tend to be at a higher risk of diabetes, the ...
Alarmingly, a further 1.3 million people are living with undiagnosed type 2 diabetes meaning that more than 12 million adults in the UK now have either diabetes or prediabetes. Prediabetes, often ...
The charity revealed that 10.81 percent of people in Bradford, 12,116 residents, have been diagnosed with diabetes, compared to 6.9 percent of the wider population across the UK.
Eli Lilly's diabetes drug Mounjaro has gained the backing of Britain's healthcare cost-effectiveness watchdog, which said it would be a good option for patients with poorly controlled type 2 diabetes.